Hims & Hers Health, Inc. (HIMS) Q3 2026 earnings results
Hims & Hers Health, Inc. (HIMS) reported Q3 2026 results on Nov 9, 2026, 4:11:11 PM ET: GAAP EPS -$0.14 vs. $0.06 expected (miss by $0.20); revenue $890.37M vs. $892.77M expected (miss by 0.3%). Outlook: Full year 2026 revenue guidance is $3.13 billion to $3.15 billion.
| Metric | Reported | Analyst estimate | Result |
|---|---|---|---|
| EPS (GAAP, diluted) | -$0.14 | $0.06 | Miss by $0.20 |
| Revenue | $890.37M | $892.77M | Miss by 0.3% |
Analyst estimate: the average forecast before the release.
Source
Figures from the SEC 8-K filing, released Nov 9, 2026, 4:11:11 PM ET. Nexqual published them 38 seconds after release. Each figure is confirmed by two independent extraction methods before it is published.
Year over year
Compared with the same quarter a year earlier (ended September 30, 2025, from the company's SEC filing): revenue grew 48.6% from $598.98M; GAAP diluted EPS was -$0.14 vs. $0.06.
Stock reaction
The results came out after the market closed. HIMS is trading at $18.87 as of 11:32 AM ET on November 10, 2026, down 17.7% from its $22.94 close on November 9, 2026 before the results.
Questions and answers
Did Hims & Hers Health, Inc. beat earnings expectations?
No. Hims & Hers Health, Inc. reported GAAP EPS of -$0.14 against an average analyst estimate of $0.06 (miss by $0.20), and revenue of $890.37M against $892.77M expected (miss by 0.3%).
What were Hims & Hers Health, Inc.'s Q3 2026 earnings and revenue?
GAAP diluted EPS of -$0.14 and revenue of $890.37M. Compared with the same quarter a year earlier (ended September 30, 2025, from the company's SEC filing): revenue grew 48.6% from $598.98M; GAAP diluted EPS was -$0.14 vs. $0.06.
When did Hims & Hers Health, Inc. report Q3 2026 earnings?
Nov 9, 2026, 4:11:11 PM ET, in an SEC 8-K filing (Item 2.02).
How did HIMS stock react to the earnings?
The results came out after the market closed. HIMS is trading at $18.87 as of 11:32 AM ET on November 10, 2026, down 17.7% from its $22.94 close on November 9, 2026 before the results.
What did Hims & Hers Health, Inc. say about its outlook?
Full year 2026 revenue guidance is $3.13 billion to $3.15 billion.
More on HIMS
HIMS stock page: price, SEC financials, insider trades, superinvestor holders, analyst estimates and options. All results reported that day: earnings November 9, 2026.
Source: SEC EDGAR 8-K (Item 2.02), Nexqual Earnings Flash. Built November 10, 2026 at 16:32 UTC. Not investment advice.
Data source: Nexqual. Last updated: November 10, 2026 at 16:32 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt